APO Research

APO RESEARCH · REPORT

Vasopressin V1b Receptor

Selected research

Industry Growth & Trends

Global Vasopressin V1b Receptor Industry Growth and Trends Forecast to 2032

Market perspective

The global Vasopressin V1b Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vasopressin V1b Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vasopressin V1b Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vasopressin V1b Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vasopressin V1b Receptor include Allergan Plc, AbbVie Inc., Orphan Therapeutics, LLC, Laboratorio ELEA S.A.C.I.F. y A. and Azevan Pharmaceuticals, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vasopressin V1b Receptor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vasopressin V1b Receptor market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vasopressin V1b Receptor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vasopressin V1b Receptor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vasopressin V1b Receptor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vasopressin V1b Receptor Market by Company

Allergan Plc

AbbVie Inc.

Orphan Therapeutics, LLC

Laboratorio ELEA S.A.C.I.F. y A.

Azevan Pharmaceuticals, Inc.

Vasopressin V1b Receptor Segment by Type

ABT-436

AVN-628

PHT-103

Others

Vasopressin V1b Receptor Segment by Application

Hospital

Clinic

Others

Vasopressin V1b Receptor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vasopressin V1b Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vasopressin V1b Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vasopressin V1b Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vasopressin V1b Receptor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vasopressin V1b Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ABT-436 Table 2. Major Company of AVN-628 Table 3. Major Company of PHT-103 Table 4. Major Company of Others Table 5. Global Vasopressin V1b Receptor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Vasopressin V1b Receptor Sales by Type (2021-2026) & (W Units) Table 7. Global Vasopressin V1b Receptor Sales Market Share in Volume by Type (2021-2026) Table 8. Global Vasopressin V1b Receptor Sales by Type (2021-2026) & (US$ Million) Table 9. Global Vasopressin V1b Receptor Sales Market Share in Value by Type (2021-2026) Table 10. Global Vasopressin V1b Receptor Price by Type (2021-2026) & (US$/Unit) Table 11. Global Vasopressin V1b Receptor Sales by Type (2027-2032) & (W Units) Table 12. Global Vasopressin V1b Receptor Sales Market Share in Volume by Type (2027-2032) Table 13. Global Vasopressin V1b Receptor Sales by Type (2027-2032) & (US$ Million) Table 14. Global Vasopressin V1b Receptor Sales Market Share in Value by Type (2027-2032) Table 15. Global Vasopressin V1b Receptor Price by Type (2027-2032) & (US$/Unit) Table 16. North America Vasopressin V1b Receptor Sales by Type (2021-2026) & (W Units) Table 17. North America Vasopressin V1b Receptor Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Vasopressin V1b Receptor Sales by Type (2021-2026) & (W Units) Table 19. Europe Vasopressin V1b Receptor Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Vasopressin V1b Receptor Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Vasopressin V1b Receptor Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Vasopressin V1b Receptor Sales by Type (2021-2026) & (W Units) Table 23. Latin America Vasopressin V1b Receptor Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Vasopressin V1b Receptor Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Vasopressin V1b Receptor Sales by Type (2021-2026) & (US$ Million) Table 26. Vasopressin V1b Receptor Industry Trends Table 27. Vasopressin V1b Receptor Industry Drivers Table 28. Vasopressin V1b Receptor Industry Opportunities and Challenges Table 29. Vasopressin V1b Receptor Industry Restraints Table 30. Global Vasopressin V1b Receptor Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Vasopressin V1b Receptor Revenue Market Share by Company (2021-2026) Table 32. Global Vasopressin V1b Receptor Sales by Company (2021-2026) & (W Units) Table 33. Global Vasopressin V1b Receptor Sales Share by Company (2021-2026) Table 34. Global Vasopressin V1b Receptor Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Vasopressin V1b Receptor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Vasopressin V1b Receptor Major Company Production Sites and Headquarters Table 37. Global Vasopressin V1b Receptor Company, Product Type & Application Table 38. Global Vasopressin V1b Receptor Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Vasopressin V1b Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Vasopressin V1b Receptor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Vasopressin V1b Receptor Sales by Region (2021-2026) & (W Units) Table 43. Global Vasopressin V1b Receptor Sales Market Share in Volume by Region (2021-2026) Table 44. Global Vasopressin V1b Receptor Sales by Region (2021-2026) & (US$ Million) Table 45. Global Vasopressin V1b Receptor Sales Market Share in Value by Region (2021-2026) Table 46. Global Vasopressin V1b Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Vasopressin V1b Receptor Sales by Region (2027-2032) & (W Units) Table 48. Global Vasopressin V1b Receptor Sales Market Share in Volume by Region (2027-2032) Table 49. Global Vasopressin V1b Receptor Sales by Region (2027-2032) & (US$ Million) Table 50. Global Vasopressin V1b Receptor Sales Market Share in Value by Region (2027-2032) Table 51. Global Vasopressin V1b Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Vasopressin V1b Receptor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Vasopressin V1b Receptor Sales by Application (2021-2026) & (W Units) Table 54. Global Vasopressin V1b Receptor Sales Market Share in Volume by Application (2021-2026) Table 55. Global Vasopressin V1b Receptor Sales by Application (2021-2026) & (US$ Million) Table 56. Global Vasopressin V1b Receptor Sales Market Share in Value by Application (2021-2026) Table 57. Global Vasopressin V1b Receptor Price by Application (2021-2026) & (US$/Unit) Table 58. Global Vasopressin V1b Receptor Sales by Application (2027-2032) & (W Units) Table 59. Global Vasopressin V1b Receptor Sales Market Share in Volume by Application (2027-2032) Table 60. Global Vasopressin V1b Receptor Sales by Application (2027-2032) & (US$ Million) Table 61. Global Vasopressin V1b Receptor Sales Market Share in Value by Application (2027-2032) Table 62. Global Vasopressin V1b Receptor Price by Application (2027-2032) & (US$/Unit) Table 63. North America Vasopressin V1b Receptor Sales by Application (2021-2026) & (W Units) Table 64. North America Vasopressin V1b Receptor Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Vasopressin V1b Receptor Sales by Application (2021-2026) & (W Units) Table 66. Europe Vasopressin V1b Receptor Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Vasopressin V1b Receptor Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Vasopressin V1b Receptor Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Vasopressin V1b Receptor Sales by Application (2021-2026) & (W Units) Table 70. Latin America Vasopressin V1b Receptor Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Vasopressin V1b Receptor Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Vasopressin V1b Receptor Sales by Application (2021-2026) & (US$ Million) Table 73. Allergan Plc Company Information Table 74. Allergan Plc Business Overview Table 75. Allergan Plc Vasopressin V1b Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Allergan Plc Vasopressin V1b Receptor Product Portfolio Table 77. Allergan Plc Recent Development Table 78. AbbVie Inc. Company Information Table 79. AbbVie Inc. Business Overview Table 80. AbbVie Inc. Vasopressin V1b Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. AbbVie Inc. Vasopressin V1b Receptor Product Portfolio Table 82. AbbVie Inc. Recent Development Table 83. Orphan Therapeutics, LLC Company Information Table 84. Orphan Therapeutics, LLC Business Overview Table 85. Orphan Therapeutics, LLC Vasopressin V1b Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Orphan Therapeutics, LLC Vasopressin V1b Receptor Product Portfolio Table 87. Orphan Therapeutics, LLC Recent Development Table 88. Laboratorio ELEA S.A.C.I.F. y A. Company Information Table 89. Laboratorio ELEA S.A.C.I.F. y A. Business Overview Table 90. Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Product Portfolio Table 92. Laboratorio ELEA S.A.C.I.F. y A. Recent Development Table 93. Azevan Pharmaceuticals, Inc. Company Information Table 94. Azevan Pharmaceuticals, Inc. Business Overview Table 95. Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Product Portfolio Table 97. Azevan Pharmaceuticals, Inc. Recent Development Table 98. North America Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 99. North America Vasopressin V1b Receptor Sales by Country (2021-2026) & (W Units) Table 100. North America Vasopressin V1b Receptor Sales Market Share by Country (2021-2026) Table 101. North America Vasopressin V1b Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 102. North America Vasopressin V1b Receptor Sales Market Share Forecast by Country (2027-2032) Table 103. North America Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Vasopressin V1b Receptor Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Vasopressin V1b Receptor Market Share by Country (2021-2026) Table 106. North America Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Vasopressin V1b Receptor Market Share Forecast by Country (2027-2032) Table 108. Europe Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 109. Europe Vasopressin V1b Receptor Sales by Country (2021-2026) & (W Units) Table 110. Europe Vasopressin V1b Receptor Sales Market Share by Country (2021-2026) Table 111. Europe Vasopressin V1b Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 112. Europe Vasopressin V1b Receptor Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Vasopressin V1b Receptor Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Vasopressin V1b Receptor Market Share by Country (2021-2026) Table 116. Europe Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Vasopressin V1b Receptor Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Vasopressin V1b Receptor Sales by Country (2021-2026) & (W Units) Table 120. Asia-Pacific Vasopressin V1b Receptor Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Vasopressin V1b Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 122. Asia-Pacific Vasopressin V1b Receptor Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Vasopressin V1b Receptor Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Vasopressin V1b Receptor Market Share by Country (2021-2026) Table 126. Asia-Pacific Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Vasopressin V1b Receptor Market Share Forecast by Country (2027-2032) Table 128. Latin America Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 129. Latin America Vasopressin V1b Receptor Sales by Country (2021-2026) & (W Units) Table 130. Latin America Vasopressin V1b Receptor Sales Market Share by Country (2021-2026) Table 131. Latin America Vasopressin V1b Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 132. Latin America Vasopressin V1b Receptor Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Vasopressin V1b Receptor Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Vasopressin V1b Receptor Market Share by Country (2021-2026) Table 136. Latin America Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Vasopressin V1b Receptor Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Vasopressin V1b Receptor Sales by Country (2021-2026) & (W Units) Table 140. Middle East and Africa Vasopressin V1b Receptor Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Vasopressin V1b Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 142. Middle East and Africa Vasopressin V1b Receptor Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Vasopressin V1b Receptor Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Vasopressin V1b Receptor Market Share by Country (2021-2026) Table 146. Middle East and Africa Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Vasopressin V1b Receptor Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Vasopressin V1b Receptor Distributors List Table 151. Vasopressin V1b Receptor Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Vasopressin V1b Receptor Image Figure 2. Global Vasopressin V1b Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vasopressin V1b Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Vasopressin V1b Receptor Sales (2021-2032) & (W Units) Figure 5. ABT-436 Image Figure 6. Global ABT-436 Sales YoY Growth (2021-2032) & (W Units) Figure 7. AVN-628 Image Figure 8. Global AVN-628 Sales YoY Growth (2021-2032) & (W Units) Figure 9. PHT-103 Image Figure 10. Global PHT-103 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Vasopressin V1b Receptor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Vasopressin V1b Receptor Market Share by Type 2025 VS 2032 Figure 15. North America Vasopressin V1b Receptor Sales Market Share in Volume by Type in 2025 Figure 16. North America Vasopressin V1b Receptor Sales Market Share in Value by Type in 2025 Figure 17. Europe Vasopressin V1b Receptor Sales Market Share in Volume by Type in 2025 Figure 18. Europe Vasopressin V1b Receptor Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Vasopressin V1b Receptor Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Vasopressin V1b Receptor Sales Market Share in Value by Type in 2025 Figure 21. Latin America Vasopressin V1b Receptor Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Vasopressin V1b Receptor Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Vasopressin V1b Receptor Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Vasopressin V1b Receptor Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Vasopressin V1b Receptor Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 33. Global Vasopressin V1b Receptor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Vasopressin V1b Receptor Market Share by Application 2025 VS 2032 Figure 35. North America Vasopressin V1b Receptor Sales Market Share in Volume by Application in 2025 Figure 36. North America Vasopressin V1b Receptor Sales Market Share in Value by Application in 2025 Figure 37. Europe Vasopressin V1b Receptor Sales Market Share in Volume by Application in 2025 Figure 38. Europe Vasopressin V1b Receptor Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Vasopressin V1b Receptor Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Vasopressin V1b Receptor Sales Market Share in Value by Application in 2025 Figure 41. Latin America Vasopressin V1b Receptor Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Vasopressin V1b Receptor Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Vasopressin V1b Receptor Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Vasopressin V1b Receptor Sales Market Share in Value by Application in 2025 Figure 45. North America Vasopressin V1b Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. North America Vasopressin V1b Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Vasopressin V1b Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Vasopressin V1b Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Vasopressin V1b Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Europe Vasopressin V1b Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Vasopressin V1b Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Vasopressin V1b Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Vasopressin V1b Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Asia-Pacific Vasopressin V1b Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Vasopressin V1b Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Vasopressin V1b Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Vasopressin V1b Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Latin America Vasopressin V1b Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Vasopressin V1b Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Vasopressin V1b Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Vasopressin V1b Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Middle East and Africa Vasopressin V1b Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Vasopressin V1b Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Vasopressin V1b Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Vasopressin V1b Receptor Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Vasopressin V1b Receptor Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • ABT-436
  • AVN-628
  • PHT-103
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Allergan Plc
  • AbbVie Inc.
  • Orphan Therapeutics, LLC
  • Laboratorio ELEA S.A.C.I.F. y A.
  • Azevan Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vasopressin V1b Receptor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vasopressin V1b Receptor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vasopressin V1b Receptor Market by Type
  6. 1.3.1 ABT-436
  7. 1.3.2 AVN-628
  8. 1.3.3 PHT-103
  9. 1.3.4 Others
  10. 1.4 Global Vasopressin V1b Receptor Market Size by Type
  11. 1.4.1 Global Vasopressin V1b Receptor Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Vasopressin V1b Receptor Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Vasopressin V1b Receptor Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Vasopressin V1b Receptor Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Vasopressin V1b Receptor Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Vasopressin V1b Receptor Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Vasopressin V1b Receptor Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Vasopressin V1b Receptor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vasopressin V1b Receptor Industry Trends
  2. 2.2 Vasopressin V1b Receptor Industry Drivers
  3. 2.3 Vasopressin V1b Receptor Industry Opportunities and Challenges
  4. 2.4 Vasopressin V1b Receptor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vasopressin V1b Receptor Revenue (2021-2026)
  2. 3.2 Global Top Players by Vasopressin V1b Receptor Sales (2021-2026)
  3. 3.3 Global Top Players by Vasopressin V1b Receptor Price (2021-2026)
  4. 3.4 Global Vasopressin V1b Receptor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vasopressin V1b Receptor Major Company Production Sites & Headquarters
  6. 3.6 Global Vasopressin V1b Receptor Company, Product Type & Application
  7. 3.7 Global Vasopressin V1b Receptor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vasopressin V1b Receptor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vasopressin V1b Receptor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vasopressin V1b Receptor Tier 1, Tier 2, and Tier 3
4 Vasopressin V1b Receptor Regional Status and Outlook
  1. 4.1 Global Vasopressin V1b Receptor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vasopressin V1b Receptor Historic Market Size by Region
  3. 4.2.1 Global Vasopressin V1b Receptor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vasopressin V1b Receptor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vasopressin V1b Receptor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vasopressin V1b Receptor Forecasted Market Size by Region
  7. 4.3.1 Global Vasopressin V1b Receptor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vasopressin V1b Receptor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vasopressin V1b Receptor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vasopressin V1b Receptor by Application
  1. 5.1 Vasopressin V1b Receptor Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Vasopressin V1b Receptor Market Size by Application
  6. 5.2.1 Global Vasopressin V1b Receptor Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Vasopressin V1b Receptor Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Vasopressin V1b Receptor Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Vasopressin V1b Receptor Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Vasopressin V1b Receptor Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Vasopressin V1b Receptor Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Vasopressin V1b Receptor Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Vasopressin V1b Receptor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Allergan Plc
  2. 6.1.1 Allergan Plc Company Information
  3. 6.1.2 Allergan Plc Business Overview
  4. 6.1.3 Allergan Plc Vasopressin V1b Receptor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Allergan Plc Vasopressin V1b Receptor Product Portfolio
  6. 6.1.5 Allergan Plc Recent Developments
  7. 6.2 AbbVie Inc.
  8. 6.2.1 AbbVie Inc. Company Information
  9. 6.2.2 AbbVie Inc. Business Overview
  10. 6.2.3 AbbVie Inc. Vasopressin V1b Receptor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Inc. Vasopressin V1b Receptor Product Portfolio
  12. 6.2.5 AbbVie Inc. Recent Developments
  13. 6.3 Orphan Therapeutics, LLC
  14. 6.3.1 Orphan Therapeutics, LLC Company Information
  15. 6.3.2 Orphan Therapeutics, LLC Business Overview
  16. 6.3.3 Orphan Therapeutics, LLC Vasopressin V1b Receptor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Orphan Therapeutics, LLC Vasopressin V1b Receptor Product Portfolio
  18. 6.3.5 Orphan Therapeutics, LLC Recent Developments
  19. 6.4 Laboratorio ELEA S.A.C.I.F. y A.
  20. 6.4.1 Laboratorio ELEA S.A.C.I.F. y A. Company Information
  21. 6.4.2 Laboratorio ELEA S.A.C.I.F. y A. Business Overview
  22. 6.4.3 Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Product Portfolio
  24. 6.4.5 Laboratorio ELEA S.A.C.I.F. y A. Recent Developments
  25. 6.5 Azevan Pharmaceuticals, Inc.
  26. 6.5.1 Azevan Pharmaceuticals, Inc. Company Information
  27. 6.5.2 Azevan Pharmaceuticals, Inc. Business Overview
  28. 6.5.3 Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Product Portfolio
  30. 6.5.5 Azevan Pharmaceuticals, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Vasopressin V1b Receptor Sales by Country
  2. 7.1.1 North America Vasopressin V1b Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vasopressin V1b Receptor Sales by Country (2021-2026)
  4. 7.1.3 North America Vasopressin V1b Receptor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vasopressin V1b Receptor Market Size by Country
  6. 7.2.1 North America Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vasopressin V1b Receptor Market Size by Country (2021-2026)
  8. 7.2.3 North America Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vasopressin V1b Receptor Sales by Country
  2. 8.1.1 Europe Vasopressin V1b Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vasopressin V1b Receptor Sales by Country (2021-2026)
  4. 8.1.3 Europe Vasopressin V1b Receptor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vasopressin V1b Receptor Market Size by Country
  6. 8.2.1 Europe Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vasopressin V1b Receptor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vasopressin V1b Receptor Sales by Country
  2. 9.1.1 Asia-Pacific Vasopressin V1b Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vasopressin V1b Receptor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vasopressin V1b Receptor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vasopressin V1b Receptor Market Size by Country
  6. 9.2.1 Asia-Pacific Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vasopressin V1b Receptor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vasopressin V1b Receptor Sales by Country
  2. 10.1.1 South America Vasopressin V1b Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vasopressin V1b Receptor Sales by Country (2021-2026)
  4. 10.1.3 South America Vasopressin V1b Receptor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vasopressin V1b Receptor Market Size by Country
  6. 10.2.1 South America Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vasopressin V1b Receptor Market Size by Country (2021-2026)
  8. 10.2.3 South America Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vasopressin V1b Receptor Sales by Country
  2. 11.1.1 Middle East and Africa Vasopressin V1b Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vasopressin V1b Receptor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vasopressin V1b Receptor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vasopressin V1b Receptor Market Size by Country
  6. 11.2.1 Middle East and Africa Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vasopressin V1b Receptor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vasopressin V1b Receptor Value Chain Analysis
  2. 12.1.1 Vasopressin V1b Receptor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vasopressin V1b Receptor Production Mode & Process
  7. 12.2 Vasopressin V1b Receptor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vasopressin V1b Receptor Distributors
  10. 12.2.3 Vasopressin V1b Receptor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research